Darapladib: all 21 studies that test it
Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
- Lipoprotein-associated Phospholipase A2 (Lp-PLA2) Progenitor Cells and Coronary Atherosclerosis in HumansCompletedNCT01067339Phase 3Results posted
- The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 TrialCompletedNCT01000727Phase 3Results posted
- The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy TrialCompletedNCT00799903Phase 3Results posted
- A Phase II Clinical Study of SB-480848 in Dyslipidemic PatientsCompletedNCT00734032Phase 2Results posted
- Integrated Biomarker And Imaging Study - 2CompletedNCT00268996Phase 2Results posted
- Effect of Darapladib on Cantharidin-Induced Inflammatory Blisters in Subjects With Type 2 Diabetes Mellitus (T2DM)CompletedNCT02058641Phase 1
- Darapladib China PKCompletedNCT02000804Phase 1
- Study to Determine the Effect of 14 Days Dosing With Darapladib (SB-480848) on Carotid Plague Composition in Patients With Planned Carotid EndarterectomyCompletedNCT01916720Phase 2
- Pharmacokinetic Interaction of Darapladib and CYP 3A4 in Healthy SubjectsCompletedNCT01873339Phase 1
- Study to Determine the Effect of Repeated Administration of Diltiazem on the Pharmacokinetics of Darapladib (Sb-480848).CompletedNCT01852565Phase 1
- To Estimate the Potential Effects of Repeat Doses of Darapladib on the Pharmacokinetics (PK) of Rosuvastatin as Well as Evaluating Safety and Tolerability in Healthy VolunteersCompletedNCT01751074Phase 1
- A Study to Assess the Pharmacokinetics, Safety and Tolerability of Repeat Oral Doses of Darapladib (SB-480848) in Subjects With Severe Renal ImpairmentCompletedNCT01711723Phase 1
- A Phase 2 Clinical Study to Investigate Effects of Darapladib in Subjects With Diabetic Macular EdemaCompletedNCT01506895Phase 2
- Study to Evaluate Darapladib in Moderately Hepatically Impaired SubjectsCompletedNCT01154114Phase 1
- A Healthy Volunteer Pharmacokinetic Study of Single and Repeat Doses of SB-480848CompletedNCT00743860Phase 1
- A Study With Darapladib to Collect Tolerability InformationCompletedNCT00704431Phase 1
- Phase I Study of SB-480848(Darapladib) -Repeat Dose Study in Healthy Japanese Male Subjects-CompletedNCT00622830Phase 1
- A Study Investigating the Concentrations of Darapladib in Blood and the Safety of This Compound in Healthy Japanese MenCompletedNCT00551317Phase 1
- Study Of The Effects Of SB 480848 (Darapladib) On The Electrical Conduction Of The HeartCompletedNCT00411073Phase 1
- A Study To Determine The Effect Of SB-480848 On AsthmaCompletedNCT00368576Phase 1
- SB-480848 In Subjects With Coronary Heart DiseaseCompletedNCT00269048Phase 2